Can Enhancement Pattern in Normal-Sized Optic Nerves on Magnetic Resonance Imaging Better Predict Tumor Invasion in Retinoblastoma Eyes?

Extraocular retinoblastoma Ocular oncology Ocular pathology Ocular radiology Optic nerve enhancement

Journal

Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 02 11 2022
accepted: 18 05 2023
medline: 30 10 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: ppublish

Résumé

Optic nerve (ON) enhancement alone without ON thickening on contrast-enhanced magnetic resonance imaging (CE-MRI) can be associated with post-laminar optic nerve invasion (PLONI) in eyes with group E retinoblastoma. A few case reports and retrospective studies in the literature show a poor correlation between ON enhancement on MRI and ON invasion on histopathological examination (HPE). There is no universal consensus on the management of such cases. It is desirable that the presence and extent of a true ON invasion be reliably picked up before planning upfront enucleation in order to avoid stage II disease. In a prospective study conducted at a tertiary eye care center in North India, all retinoblastoma patients presenting with ON enhancement on imaging were evaluated. Demographic and imaging details, histopathological findings, and treatment details were recorded. The length and pattern of enhancement noted on MRI were correlated with histopathology. Follow-up was done till the end of the study period. Six group E retinoblastoma eyes were evaluated. 3 eyes (50%) showed solid enhancement, 2 eyes (33.33%) had tram track pattern and 1 eye (16.66%) showed punctate enhancement pattern on CE-MRI. On histopathology, 5 (83.33%) cases showed PLONI and all 6 (100%) had ON head infiltration. The cut end of the ON was free in all cases. On correlating MRI and HPE, all eyes with solid enhancement pattern showed PLONI, of which 2/3 (66.6%) had diffuse ON infiltration. Only 50% of eyes with tram track patterns showed PLONI. The case which showed a punctate enhancement pattern showed focal infiltration by tumor cells with vacuolated cytoplasm on HPE. At the last follow-up, all patients were alive and free of disease. ON enhancement patterns may make it more predictive for PLONI on HPE. Solid enhancement pattern appears to correlate better with the extent of ON invasion on HPE, and longer lengths of solid ON enhancement may be considered for neoadjuvant chemotherapy rather than upfront enucleation.

Identifiants

pubmed: 37900190
doi: 10.1159/000531354
pii: 531354
pmc: PMC10601867
doi:

Types de publication

Journal Article

Langues

eng

Pagination

107-114

Informations de copyright

© 2023 S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Ophthalmic Genet. 2020 Feb;41(1):69-72
pubmed: 32072844
Indian J Ophthalmol. 2019 Dec;67(12):2019-2022
pubmed: 31755442
Arch Pathol Lab Med. 2009 Aug;133(8):1199-202
pubmed: 19653709
Eur Radiol. 2015 May;25(5):1443-52
pubmed: 25433413
Pediatr Radiol. 2007 Jul;37(7):649-56
pubmed: 17479257
Eur J Radiol. 2012 Dec;81(12):4041-5
pubmed: 23017191
Ophthalmology. 2022 Nov;129(11):1275-1286
pubmed: 35752210
Radiology. 2005 Apr;235(1):197-207
pubmed: 15695620
Br J Ophthalmol. 2013 Jan;97(1):52-8
pubmed: 23117972
Eur Radiol. 1997;7(5):726-31
pubmed: 9166573
Br J Ophthalmol. 2003 Mar;87(3):330-5
pubmed: 12598449
Pediatr Blood Cancer. 2008 Oct;51(4):479-84
pubmed: 18478574
Ocul Oncol Pathol. 2016 Apr;2(3):178-80
pubmed: 27239461
JAMA. 1997 Oct 15;278(15):1262-7
pubmed: 9333268
Br J Ophthalmol. 2006 Jun;90(6):800-1
pubmed: 16714275

Auteurs

Madhu Chiranthan (M)

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Rachna Meel (R)

Department of Oculoplasty and Ocular Oncology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Sanjay Sharma (S)

Department of Ocular Radiology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Neiwete Lomi (N)

Department of Oculoplasty and Ocular Oncology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Seema Kashyap (S)

Department of Ocular Pathology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Mandeep S Bajaj (MS)

Department of Oculoplasty and Ocular Oncology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Classifications MeSH